About this trial
The PMMHRI-Pitavastatin Registry is a non-interventional, single-center registry conducted at the Polish Mother's Memorial Hospital Research Institute (PMMHRI). Established in January 2024, the registry enrolls all patients from the Department of Cardiology and Adult Congenital Heart Diseases, the Department of Endocrinology, as well as outpatient cardiology and endocrinology clinics who are prescribed pitavastatin.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patient takling pitavastatin based on the 2021 Polish Lipid Guidelines
Disqualifiers
None
Trial population
Patients of the Department of Cardiology and Adult Congenital Heart Diseases, Department of Endocrinology, and outpatient cardiology and endocrinology clinics who is taking pitavastatin.
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Patient's characteristic.
Characteristic of patients treated with pitavastatin among the Polish population.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.